10X Genomics Inc
10X Genomics (TXG) is a life‑science tools company that develops instruments, consumables and software for single‑cell and spatial genomics used in research and discovery. Investors should know it is a growth‑oriented business that relies on sales of capital instruments to build an installed base and recurring revenue from higher‑margin reagents and analysis software. Its technology is used across oncology, immunology, neuroscience and cell therapy research, offering exposure to expanding scientific workflows but also to research funding cycles and adoption rates. The company has historically prioritised product development and commercial expansion over short‑term profitability, which can lead to variable earnings and cash use; market capitalisation is about $1.62bn. Key risks include competition from larger instrument makers, execution on new products, and sensitivity to research budgets. This is general educational information, not personal advice — values can fall as well as rise, and you should consider suitability, time horizon and risk tolerance or consult a financial adviser.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying 10X Genomics stock with a target price of $18.81, indicating growth potential.
Financial Health
10X Genomics is showing strong revenue and cash flow, with healthy profit margins as well.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TXG
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketPatient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Published: June 17, 2025
Explore BasketNew Moon Portfolio
This collection represents the very beginning of the next technological cycle. These carefully selected companies are sowing the seeds of future industries, giving you early exposure to disruptive innovators poised for exponential growth as their technologies reshape our world.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables
Revenue from reagents and software can give a recurring stream as the installed base grows, though sales depend on research funding and competitive dynamics.
Expanding Applications
Single‑cell and spatial techniques are finding wider use across oncology and cell therapy discovery, presenting long‑term opportunity while adoption may take time.
Execution & Cash
Execution on product launches and margin improvement matters; the company’s investment focus has previously impacted short‑term profitability and cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
